PMID- 35041115 OWN - NLM STAT- MEDLINE DCOM- 20220523 LR - 20220523 IS - 1590-3478 (Electronic) IS - 1590-1874 (Linking) VI - 43 IP - 6 DP - 2022 Jun TI - Serum NfL associated with anti-NMDA receptor encephalitis. PG - 3893-3899 LID - 10.1007/s10072-021-05838-3 [doi] AB - INTRODUCTION: Neurofilament light chains (NfL) have been reported as potential markers for neuronal-axonal injury in neuroinflammatory diseases. In the current study, we describe serum NfL levels as a prognostic marker for anti-N-methyl-D-aspartate receptor encephalitis (NMDARE). METHODS: Serum levels of NfL of 64 patients with anti-NMDARE and 84 healthy controls were measured by Simoa. The anti-NMDAR Encephalitis One-Year Functional Status (NEOS) score, Modified Rankin Scale (mRS) scores, and clinical and cerebrospinal fluid parameters were evaluated in patients with anti-NMDARE. Meanwhile, we performed a receiver-operator characteristic analysis to assess the power of the serum NFL in predicting the 1-year functional status. RESULTS: Serum NfL levels were significantly elevated in patients with anti-NMDARE compared to healthy controls (p < 0.001, p(adjusted) < 0.001), especially in patients with severe impairments (mRS > 3 vs